Effectiveness of staged excisions for treating lentiginous melanoma in situ

Expert Review of Dermatology

Volumn 3, Issue 5, 2008, Pages 549-555

  Abdelmalek, Mark ^a   Abramova, Liana ^b   Hurt, Mark A ^c   Hruza, George ^d  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WCP Laboratories Inc   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lentigo maligna; Margin; Melanoma; Melanoma in situ; Staged excision

Indexed keywords

IMIQUIMOD;

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOSURGERY; CLINICAL FEATURE; CLINICAL TRIAL; CRYOSURGERY; CURETTAGE; DERMIS; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; LASER SURGERY; MALIGNANT LENTIGO; MELANOMA; PATIENT SAFETY; PRIORITY JOURNAL; RECURRENCE RISK; SKIN BIOPSY; SKIN GRAFT; SKIN SURGERY; SURGICAL TECHNIQUE; TISSUE SECTION; TREATMENT RESPONSE;

EID: 55249116039     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.5.549     Document Type: Article

References (46)

1. Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol. Surg. 21(4), 285-290 (1995).
2. American Cancer Society. Cancer Facts and Figures 1997-2008. New York, NY, USA.
3. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subytpes: northern California and national trends 1990-2000. J. Invest. Dermatol. 125, 685-691 (2005).
4. Hutchinson J. Senile freckles. Arch. Surg. 3, 319-322 (1892).
5. Hutchinson J. Notes on the cancerous process and on new growths in general. Arch. Surg. 2, 83-86 (1890).
6. Hutchinson J. Lentigo-melanosis: a further report. Arch. Surg. 5, 253-256 (1894).
7. McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol. Surg. 32, 493-504 (2006).
8. Mahoney EJ, Dolan RW, Choi EE, Olbricht SM. Surgical reconstruction of lentigo maligna defects. Arch. Facial Plast. Surg. 7, 342-346 (2005).
9. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J. Am. Acad. Dermatol. 33 (6), 923-936 (1995).
10. Johnson TM, Headington JT, Baker SR, Lowe L. Usefullness of the staged excision for lentigo maligna and lentigo maligna melanoma: the 'square' procedure. J. Am. Acad. Dermatol. 37(5), 758-764 (1997).
11. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br. J. Dermatol. 116, 303-310 (1987).
12. Jackson R, Williamson G, Beattie W. Lentigo maligna and lentigo, maligna melanoma. Can. Med. Assoc. J. 95, 846-851 (1966).
13. Davis J, Pack GT, Higgins G. Melanotic freckle of Hutchinson. Am. J. Surg. 113, 457-463 (1967).
14. Blodi FC, Widner RR. The melanotic freckle (Hutchinson) of the lids. Surv. Ophthalmol. 13, 23-30 (1968).
15. Kuflik EG, Gage AA. Cryosurgery for lentigo, maligna. J. Am. Acad. Dermatol. 31(1), 75-78 (1994).
16. Graham GF. Advances in cryosurgery during the past decade. Cutis 52(6), 365-372 (1993).
17. Bohler-Sommeregger K, Schuller-Petrovic S, Neumann R, Muller E. Cryosurgery of lentigo maligna. Plast. Reconstr. Surg. 90(3), 436-440 (1992).
18. Zalaudek I, Horn M, Richtig E, Hodl S, Kerl H, Smolle J. Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities. Br. J. Dermatol. 148, 703-708 (2003).
19. Cotter MA, McKenna JK, Bowen GM. Treatment of lentigo maligna with imiquimod before staged excision. Dermatol. Surg. 34(2), 147-151 (2008).
20. Handley WS. The pathology of melanotic growths in relation to their operative treatment. Lancet 1, 927(33), 996-1003 (1907).
21. Veronesi U, Cascinelli N. Narrow excision (1 cm margin): a safe procedure for thin cutaneous melanoma. Arch. Surg. 126, 438-441 (1991).
22. Balch CM, Urist MM, Karakousis CP et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a mulit-institutional randomized surgical trial. Ann. Surg. 218, 262-269 (1993).
23. Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma. Ann. Surg. Oncol. 3, 446-452 (1996).
24. Cohn-Cedermark G, Rutqvist LE, Andersson R et al. Long-term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer 89, 1495-1501 (2000).
25. Khayat D, Rixe O, Martin G. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1 mm thick). Cancer 97, 1941-1946 (2003).
26. National Institutes of Health Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 268, 1314-1319 (1992).
27. Pitman GH, Kopf AW, Bart RS et al. Treatment of lentigo maligna and lentigo maligna melanoma. J. Dermatol. Surg. Oncol. 5, 727-737 (1959).
28. Coleman WP, Davis RS, Reed RJ et al. Treatment of lentigo maligna and lentigo maligna melanoma. J. Dermatol. Surg. Oncol. 6, 476-479 (1980).
29. Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br. J. Plast. Surg. 55, 611-615 (2002).
30. Temple CLF, Arlette JP. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J. Surg. Oncol. 94(4), 287-292 (2006).
31. Ziteli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J. Am. Acad. Dermatol. 37, 236-245 (1997).
32. Cohen LM, McCall MW, Zax RH. Mobs micrographic surgery for lentigo maligna and lentigo maligna melanoma. Dermatol. Surg. 24(6), 673-677 (1998).
33. Dhawan S, Wolf D, Rabinowitz H, Poulos E. Lentigo maligna - the use of rush permanent sections in therapy. Arch. Dermatol. 126, 928-930 (1990).
34. Huilgol S, Selva D, Chen C et al. Surgical margins for lentigo maligna and lentigo maligna melanoma- the technique of mapped serial excision. Arch. Dermatol. 140, 1087-1092 (2004).
35. Agarwal-Antan N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J. Am. Acad. Dermatol. 47(5), 743-748 (2002).
36. Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Aust. J. Dermatol. 40, 25-30 (1999).
37. Wayte DM, Helwig EB. Melanotic freckle of Hutchinson. Cancer 21, 893-911 (1968).
38. Malhotra R, Chen C, Huilgol SC, Hill DC, Selva D. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology 110(10), 2011-2018 (2003).
39. Bub JL, Berg D, Slee A, Odland PB. Management of lentigo maligna and lentigo maligna melanoma with staged excision. Arch. Dermatol. 140, 552-558 (2004).
40. Huilgol S, Selva D, Chen C et al. Surgical margins for lentigo maligna and lentigo maligna melanoma- the technique of mapped serial excision. Arch. Dermatol. 140, 1087-1092 (2004).
41. jejurikar SS, Borschel GH, Johnson TM, Lowe L, Brown DL. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast. Reconstr. Surg. 120, 1249-1255 (2007).
42. Charles CA, Yee VS, Dusza SW et al. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists. Arch. Dermatol. 141, 723-729 (2005).
43. Walling HW, Scupham RK, Bean AK, Ceilley RI et al. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J. Am. Acad. Dermatol. 57, 659-664 (2007).
44. Hazan C, Dusza SW, Delgado R, Busam KJ, Halpern AC, Nehal KS. Staged excision for lentigo maligna and lentigo maligna melanoma: A retrospective analysis of 117 cases. J. Am. Acad. Dermatol. 58(1), 142-148 (2008).
45. Florell SR, Boucher KM, Leachman SA et al. Histopathologic recognition of involved margins of lentigo, maligna excised by staged excision: an interobserver comparison study. Arch. Dermatol. 139(5), 595-604 (2003).
46. Hendi A, Brodland DG, Zitelli JA. Melanocytes in long affiliations-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch. Dermatol. 142(7), 871-876 (2006).